Cancer Prevention News and Research

RSS

KHN’s ‘What the Health?’: The FDA goes after nicotine

The FDA this week launched a crackdown on smoking and vaping — ordering the vaping device Juul to be taken off the market and announcing its intention to require makers of cigarettes and other tobacco products to reduce the amount of nicotine in them.

23 Jun 2022

Simple blood test can predict liver cancer risk in NAFLD patients

An estimated one-quarter of adults in the U.S. have nonalcoholic fatty liver disease (NAFLD), an excess of fat in liver cells that can cause chronic inflammation and liver damage, increasing the risk of liver cancer.

22 Jun 2022

New perspective shows high burden of breast cancer mortality for Black women began in the 1980's

A new perspective by researchers from the American Cancer Society and the University of Texas Health Science Center at San Antonio shows the high burden of breast cancer mortality in African American (Black) women versus White women began in the United States in the 1980's.

18 Jun 2022

International researchers will receive $25 million award to investigate the early stages of cancer development

A world-class team of researchers co-led by UC San Francisco's Allan Balmain, PhD, FRS, has been selected to receive a $25 million Cancer Grand Challenges award to investigate the very early stages of cancer development.

16 Jun 2022

Androgen receptor signaling affects response to targeted therapy in people with melanoma

Androgen receptor (AR) signaling affects response to BRAF/MEK inhibitor therapy in both males and females with melanoma, researchers from The University of Texas MD Anderson Cancer Center showed in a study published today in Nature.

15 Jun 2022

Varenicline improves quit rates among African American daily smokers

African Americans have been underrepresented in tobacco treatment research, including the clinical trials that led to the 2006 FDA approval of varenicline, the leading pharmacological treatment for smoking cessation commonly known by the brand name Chantix.

14 Jun 2022

New molecule kills a broad spectrum of hard-to-treat cancers

A new molecule synthesized by a University of Texas at Dallas researcher kills a broad spectrum of hard-to-treat cancers, including triple-negative breast cancer, by exploiting a weakness in cells not previously targeted by other drugs.

10 Jun 2022

CDC announces first-year funding of $215 million for three national programs to prevent and control cancer

The Centers for Disease Control and Prevention today announced first-year funding awards of $215 million in a 5-year, $1.1 billion investment into three national programs to prevent and control cancer.

10 Jun 2022

Genomic analysis provides a deeper understanding of DCIS biology

A new study led by the global Cancer Grand Challenges PRECISION team, including researchers from The University of Texas MD Anderson Cancer Center, shifts the long-held belief that all invasive breast cancers following ductal carcinoma in situ (DCIS) arise from the original DCIS lesion.

9 Jun 2022

USA–Japan Workshop participants present cutting-edge research on biomarkers for early detection of cancer

Successful treatment of cancer frequently depends on early detection. However, many cancers are detected late, often after metastasizing to other sites.

9 Jun 2022

Public perceptions of e-cigarettes vs. cigarettes harms influence population tobacco use patterns

A new study led by researchers at the American Cancer Society (ACS) shows perceptions of electronic or e-cigarettes as being "more harmful" than cigarettes by adults in the United States more than doubled between 2019-2020 and perceptions of e-cigarettes as "less harmful" declined between 2018-2020.

9 Jun 2022

UChicago Medicine launches new study to explore cancer causes and prevention

The University of Chicago Medicine hopes to recruit 50,000 people to participate in a new national study designed to explore the causes of cancer and learn more about how to prevent it.

8 Jun 2022

New microbubble-assisted ultrasound-guided immunotherapy helps improve anti-tumor immunity

Researchers at UT Southwestern have developed a first-of-its-kind ultrasound-guided cancer immunotherapy platform that delivers immune-stimulating agents to cells for the development of systemic anti-tumor immunity.

7 Jun 2022

Etiologies of liver cancer are changing and the prognosis is mixed, study says

The primary causes of liver cancer are well known: viral (hepatitis B and C), alcohol and non-alcoholic steatohepatitis (NASH), a condition in which fat builds up in the liver, resulting in chronic inflammation and damage.

7 Jun 2022

Phase separation discovery could lead to new interventions to regulate immune activity

Protein complexes that play a critical role in launching an immune response assemble in droplets that form within the liquid environment in cells much like oil droplets in water, UT Southwestern scientists report in a new study.

6 Jun 2022

Novel approach identifies potent drug-like molecules that bind to cancer protein of interest

Researchers at Baylor College of Medicine and Texas Children's Hospital have identified potent, highly specific compounds that interfere with bromodomain (BD)-containing proteins involved in cancer.

3 Jun 2022

Study reveals significant decline in breast, cervical, colorectal cancer screenings due to COVID-19 pandemic

New findings led by researchers at the American Cancer Society (ACS) show the number of women in the United States who reported having a recent (in the past year) breast cancer or cervical cancer screening dropped by 2.13 million (6%) and 4.47 million (11%) respectively in 2020 compared to 2018.

3 Jun 2022

Aerobic exercise amplifies the effects of immunotherapy to reduce pancreatic tumor growth

Aerobic exercise reprograms the immune system to reduce pancreatic tumor growth and amplify the effects of immunotherapy, a new study finds.

2 Jun 2022

Substances touted to improve athletic performance and high fat diet fuel pancreatic cancer’s development

Researchers at the University of Michigan Rogel Cancer Center have found a cell nuclear receptor activated by high fat diets and synthetic substances in unregulated athletic performance enhancers fuels the progression of precancerous pancreas lesions into pancreatic cancer.

1 Jun 2022

Black patients with early-onset colorectal cancer receive worse, less timely care than white counterparts

In a new large national study led by researchers at the American Cancer Society, Black patients diagnosed with early-onset colorectal cancer received worse and less timely care than their white counterparts.

31 May 2022

Cancer Prevention News and Research

KHN’s ‘What the Health?’: The FDA goes after nicotine

Simple blood test can predict liver cancer risk in NAFLD patients

New perspective shows high burden of breast cancer mortality for Black women began in the 1980's

International researchers will receive $25 million award to investigate the early stages of cancer development

Androgen receptor signaling affects response to targeted therapy in people with melanoma

Varenicline improves quit rates among African American daily smokers

New molecule kills a broad spectrum of hard-to-treat cancers

CDC announces first-year funding of $215 million for three national programs to prevent and control cancer

Genomic analysis provides a deeper understanding of DCIS biology

USA–Japan Workshop participants present cutting-edge research on biomarkers for early detection of cancer

Public perceptions of e-cigarettes vs. cigarettes harms influence population tobacco use patterns

UChicago Medicine launches new study to explore cancer causes and prevention

New microbubble-assisted ultrasound-guided immunotherapy helps improve anti-tumor immunity

Etiologies of liver cancer are changing and the prognosis is mixed, study says

Phase separation discovery could lead to new interventions to regulate immune activity

Novel approach identifies potent drug-like molecules that bind to cancer protein of interest

Study reveals significant decline in breast, cervical, colorectal cancer screenings due to COVID-19 pandemic

Aerobic exercise amplifies the effects of immunotherapy to reduce pancreatic tumor growth

Substances touted to improve athletic performance and high fat diet fuel pancreatic cancer’s development

Black patients with early-onset colorectal cancer receive worse, less timely care than white counterparts

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News